Ceridian HCM (CDAY) Stock Forecast, Price & News

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CDAY shares.
View CDAY analyst ratings or view top-rated stocks.

12 brokerages have issued twelve-month target prices for Ceridian HCM's shares. Their CDAY share price forecasts range from $65.00 to $95.00. On average, they anticipate the company's share price to reach $78.79 in the next year. This suggests a possible upside of 26.1% from the stock's current price.
View analysts price targets for CDAY or view top-rated stocks among Wall Street analysts.

Ceridian HCM's stock was trading at $64.15 on January 1st, 2023. Since then, CDAY shares have decreased by 2.6% and is now trading at $62.50.
View the best growth stocks for 2023 here.

Ceridian HCM saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 11,440,000 shares, an increase of 6.7% from the April 30th total of 10,720,000 shares. Based on an average daily volume of 1,280,000 shares, the days-to-cover ratio is presently 8.9 days. Approximately 7.7% of the company's shares are sold short.
View Ceridian HCM's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our CDAY earnings forecast.

Ceridian HCM Holding Inc. (NYSE:CDAY) issued its quarterly earnings results on Wednesday, May, 3rd. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by $0.05. The business had revenue of $370.60 million for the quarter, compared to the consensus estimate of $360.77 million. Ceridian HCM had a negative trailing twelve-month return on equity of 0.02% and a negative net margin of 2.73%.

ETFs with the largest weight of Ceridian HCM (NYSE:CDAY) stock in their portfolio include Invesco Dynamic Software ETF (PSJ), WisdomTree U.S. Growth & Momentum Fund (WGRO), Nuveen ESG Mid-Cap Growth ETF (NUMG), Invesco S&P 500 Equal Weight Technology ETF (RYT), Putnam Sustainable Future ETF (PFUT), Innovator Gradient Tactical Rotation Strategy ETF (IGTR), Hypatia Women CEO ETF (WCEO) and Pacer Lunt Large Cap Alternator ETF (ALTL).

Ceridian HCM issued an update on its second quarter 2023 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $356.00 million-$360.00 million, compared to the consensus revenue estimate of $362.54 million.

902 employees have rated Ceridian HCM Chief Executive Officer David Ossip on Glassdoor.com. David Ossip has an approval rating of 92% among the company's employees. This puts David Ossip in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Advanced Micro Devices (AMD), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Alteryx (AYX), Costco Wholesale (COST), ServiceNow (NOW), Paycom Software (PAYC) and Tesla (TSLA).

(CDAY) raised $420 million in an initial public offering on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by a number of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (13.33%), Select Equity Group L.P. (10.78%), Davidson Kempner Capital Management LP (0.00%), Cannae Holdings Inc. (3.27%), Geode Capital Management LLC (2.08%) and Artisan Partners Limited Partnership (2.03%). Insiders that own company stock include Christopher R Armstrong, David D Ossip, Gerald C Throop, Jeffrey Scott Jacobs, Joseph B Korngiebel, Leagh Erin Turner, Noemie Clemence Heuland, Rakesh Subramanian, Scott A Kitching, Thomas H Lee Advisors, Llc, Thomas M Hagerty and William Everett Mcdonald.
View institutional ownership trends.

Shares of CDAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CDAY stock can currently be purchased for approximately $62.50.

Ceridian HCM (NYSE:CDAY) has a market capitalization of $9.57 billion and generates $1.32 billion in revenue each year. The company earns $-73,400,000.00 in net income (profit) each year or ($0.24) on an earnings per share basis.

The company employs 8,526 workers across the globe.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The official website for the company is www.ceridian.com. The company can be reached via phone at (952) 853-8100 or via email at investors@ceridian.com.